EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A major locus confers triclabendazole resistance in Fasciola hepatica and shows dominant inheritance

Nicola J Beesley iD, Krystyna Cwiklinski, Katherine Allen, Rebecca C Hoyle, Terry W Spithill, E James La Course, Diana J L Williams, Steve Paterson, Jane E Hodgkinson

PLOS Pathogens · 2023

DOI: 10.1371/journal.ppat.1011081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Nicola J Beesley und 8 weiteren Autor:innen. Beteiligte Einrichtung: Veterinary Parasitology, Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom. Hauptthemen laut MEDLINE: Fasciola hepatica, Anthelmintics, Fascioliasis. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fasciola hepatica infection is responsible for substantial economic losses in livestock worldwide and poses a threat to human health in endemic areas. The mainstay of control in livestock and the only drug licenced for use in humans is triclabendazole (TCBZ). TCBZ resistance has been reported on every continent and threatens effective control of fasciolosis in many parts of the world. To date, understanding the genetic mechanisms underlying TCBZ resistance has been limited to studies of candidate genes, based on assumptions of their role in drug action. Taking an alternative approach, we combined a genetic cross with whole-genome sequencing to localise a ~3.2Mbp locus within the 1.2Gbp F . hepatica genome that confers TCBZ resistance. We validated this locus independently using bulk segregant analysis of F . hepatica populations and showed that it is the target of drug selection in the field. We genotyped individual parasites and tracked segregation and reassortment of SNPs to show that TCBZ resistance exhibits Mendelian inheritance and is conferred by a dominant allele. We defined gene content within this locus to pinpoint genes involved in membrane transport, (e.g. ATP-binding cassette family B, ABCB1), transmembrane signalling and signal transduction (e.g. GTP-Ras-adenylyl cyclase and EGF-like protein), DNA/RNA binding and transcriptional regulation (e.g. SANT/Myb-like DNA-binding domain protein) and drug storage and sequestration (e.g. fatty acid binding protein, FABP) as prime candidates for conferring TCBZ resistance. This study constitutes the first experimental cross and genome-wide approach for any heritable trait in F . hepatica and is key to understanding the evolution of drug resistance in Fasciola spp. to inform deployment of efficacious anthelmintic treatments in the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fasciola hepaticaAnthelminticsFascioliasisAnimalsHumansTriclabendazoleBenzimidazolesDrug Resistance

Substanzen

TriclabendazoleBenzimidazolesAnthelmintics

Autor:innen und Institutionen

  • Veterinary Parasitology, Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
  • Department of Animal, Plant and Soil Sciences and Centre for AgriBioscience, La Trobe University, Bundoora, Australia.
  • Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
  • Centre for Genomic Research, Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.

ORCID-Profile: Nicola J Beesley

Förderung

  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Beesley, N. J., Cwiklinski, K., Allen, K., Hoyle, R. C., Spithill, T. W., La Course, E. J., Williams, D. J. L., Paterson, S., & Hodgkinson, J. E. (2023). A major locus confers triclabendazole resistance in Fasciola hepatica and shows dominant inheritance. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011081

Vancouver

Beesley NJ, Cwiklinski K, Allen K, Hoyle RC, Spithill TW, La Course EJ, et al. A major locus confers triclabendazole resistance in Fasciola hepatica and shows dominant inheritance. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011081

BibTeX
@article{Beesley2023,
  author = {Beesley, Nicola J and Cwiklinski, Krystyna and Allen, Katherine and Hoyle, Rebecca C and Spithill, Terry W and La Course, E James and Williams, Diana J L and Paterson, Steve and Hodgkinson, Jane E},
  title = {A major locus confers triclabendazole resistance in Fasciola hepatica and shows dominant inheritance},
  journal = {PLOS Pathogens},
  year = {2023},
  doi = {10.1371/journal.ppat.1011081}
}
Kostenlos starten →